Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Colin D. Weekes, M.D., Ph.D.

Concepts (301)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms38202454442.300 Why?
Deoxycytidine920208861.190 Why?
Adenocarcinoma15202463591.090 Why?
Carcinoma, Pancreatic Ductal11202417570.960 Why?
Neuropilin-132014900.910 Why?
Antineoplastic Combined Chemotherapy Protocols282024118720.890 Why?
Paclitaxel5202317270.800 Why?
Albumins420235780.740 Why?
Neoplasms162024223500.620 Why?
Fluorouracil9202416510.600 Why?
Immunoglobulin Fc Fragments120202870.600 Why?
Diphenylamine22017490.560 Why?
Phenylurea Compounds220195330.530 Why?
Maximum Tolerated Dose920208950.530 Why?
Immunoconjugates320219760.510 Why?
Sirolimus2201315400.500 Why?
GPI-Linked Proteins220204720.490 Why?
Gastrointestinal Neoplasms420239570.420 Why?
Receptors, G-Protein-Coupled1202012450.410 Why?
Neoadjuvant Therapy9202329020.410 Why?
Quinolines120187690.400 Why?
Sulfonamides3202419820.390 Why?
Recombinant Fusion Proteins1202037380.380 Why?
Mitogen-Activated Protein Kinase 1120134780.370 Why?
Camptothecin220215990.360 Why?
Antibodies, Monoclonal4201892440.350 Why?
Protein Kinase Inhibitors7202456900.350 Why?
Chemokine CXCL12120124570.350 Why?
Thymidylate Synthase12010740.340 Why?
Antineoplastic Agents92020136430.340 Why?
Liver Neoplasms4202143530.330 Why?
Pyridines2201928880.320 Why?
Angiogenesis Inhibitors3201420570.320 Why?
Antineoplastic Agents, Phytogenic120136160.320 Why?
Carcinoma, Hepatocellular2201823260.290 Why?
Xenograft Model Antitumor Assays2201336070.290 Why?
Receptors, CXCR4120127290.290 Why?
Drug Resistance, Neoplasm4201953290.280 Why?
Neoplasm Staging112021112180.270 Why?
Leucovorin620246440.260 Why?
Biliary Tract Neoplasms220181860.240 Why?
Aged4020241713430.240 Why?
Molecular Targeted Therapy1201628230.230 Why?
Middle Aged4320242232570.220 Why?
Proto-Oncogene Proteins p21(ras)3202417620.220 Why?
TOR Serine-Threonine Kinases1201220600.210 Why?
Enhancer Elements, Genetic1201013630.210 Why?
Neoplasm, Residual2202110120.210 Why?
Mice, Nude5202436160.210 Why?
bcl-X Protein120244120.200 Why?
Treatment Outcome202024652730.200 Why?
Hypoalbuminemia12023900.200 Why?
Benzimidazoles220188620.200 Why?
Drug Administration Schedule5202148530.200 Why?
Colorectal Neoplasms4202469620.200 Why?
Humans7820247667660.200 Why?
Adult3320242233070.200 Why?
Rectal Neoplasms2202111830.200 Why?
Coronary Vasospasm12022810.190 Why?
Pyrimidinones120243850.190 Why?
Collagen Type I120246160.180 Why?
Colonic Neoplasms1201325340.180 Why?
Aged, 80 and over182024595500.180 Why?
Receptors, Lymphocyte Homing120011410.180 Why?
Indolizines12020290.180 Why?
Cyclic N-Oxides12020710.180 Why?
Lymphoma2200119000.180 Why?
Pyridinium Compounds12020800.170 Why?
Male4420243641420.170 Why?
Immunosuppressive Agents1201342150.170 Why?
Female4620243965200.170 Why?
Piperidines2202016630.160 Why?
Ovarian Neoplasms1201649040.160 Why?
Azetidines120201510.160 Why?
Neoplasm Transplantation2201320120.160 Why?
Pyridones120248180.150 Why?
Quinazolinones120202190.150 Why?
Aniline Compounds1202410790.150 Why?
Integrin alpha5beta112018360.150 Why?
Dose-Response Relationship, Drug52018107450.150 Why?
Administration, Oral4202040180.150 Why?
Stromal Cells2200113340.150 Why?
Positron-Emission Tomography3202465500.150 Why?
Pyrrolidinones120181160.140 Why?
Quinazolines2201513670.140 Why?
Heterocyclic Compounds, 3-Ring120202960.140 Why?
Losartan120192630.140 Why?
Mitogen-Activated Protein Kinase Kinases120206350.140 Why?
Pancreas3202016980.140 Why?
MAP Kinase Kinase 212017920.140 Why?
Purines120206150.140 Why?
Integrins120018390.130 Why?
Wnt Proteins120207220.130 Why?
Antigens, Surface1202016170.130 Why?
Phosphatidylinositol 3-Kinases3202028810.130 Why?
Peritoneal Neoplasms120227060.120 Why?
Bone Marrow Purging119951080.120 Why?
MAP Kinase Kinase 1120173300.120 Why?
Vaccines120248420.120 Why?
Feasibility Studies2202353060.120 Why?
Ferrosoferric Oxide120163490.120 Why?
Drug Interactions1201914190.120 Why?
Platinum120162190.120 Why?
Transplantation, Heterologous2201323910.110 Why?
Retreatment120165980.110 Why?
Hodgkin Disease1200213840.110 Why?
Social Environment1201910120.110 Why?
DNA, Neoplasm1201917410.110 Why?
Sulfones220144470.110 Why?
Tumor Microenvironment2202139440.110 Why?
Hypoxia-Inducible Factor 1, alpha Subunit120176270.110 Why?
Glycine220146700.110 Why?
MAP Kinase Signaling System1202014910.110 Why?
Antimetabolites, Antineoplastic120176460.100 Why?
Biological Assay120166260.100 Why?
Workplace120198730.100 Why?
Mucin-1120175360.100 Why?
Pyrazines1201812040.100 Why?
Receptors, CXCR12012520.100 Why?
Imidazoles1201811680.100 Why?
Mutation42024302130.100 Why?
ras Proteins2201710550.100 Why?
Chemoembolization, Therapeutic120121280.100 Why?
Radiosurgery1202113290.090 Why?
Cell Line, Tumor42024170880.090 Why?
Membrane Transport Proteins1201710290.090 Why?
Proto-Oncogene Proteins B-raf3201920560.090 Why?
Quality of Life52023134760.090 Why?
Insulin-Like Growth Factor I1201819350.090 Why?
Cyclin D1120124540.090 Why?
Magnetic Resonance Imaging42024365670.090 Why?
Neoplasm Metastasis5202048910.090 Why?
Thrombosis1202329530.080 Why?
Disease Progression42022136400.080 Why?
Patient Care Team1202025190.080 Why?
Drug Synergism1201317560.080 Why?
Tissue Distribution1201322750.080 Why?
Young Adult62021599390.080 Why?
Class I Phosphatidylinositol 3-Kinases120139040.080 Why?
Bone Marrow1199829260.070 Why?
Carcinoma, Non-Small-Cell Lung2202053870.070 Why?
Prognosis62022299480.070 Why?
RNA Interference2201728270.070 Why?
Cell Culture Techniques1199516460.070 Why?
Autophagy1201613460.070 Why?
Pancreatectomy220238250.070 Why?
High-Throughput Nucleotide Sequencing1202036660.070 Why?
Retrospective Studies112023816350.070 Why?
Drug Design1201210420.070 Why?
Proto-Oncogene Proteins c-myc120129960.070 Why?
Standard of Care220225690.070 Why?
Tumor Cells, Cultured3200161040.070 Why?
Proto-Oncogene Proteins3201445220.070 Why?
Metabolome1201310090.060 Why?
Energy Metabolism1201729030.060 Why?
Glucose1201743400.060 Why?
Cohort Studies62023417100.060 Why?
Homozygote1201017750.060 Why?
Registries1202183510.060 Why?
Demography1201016410.060 Why?
Diabetes Mellitus1202358870.060 Why?
Signal Transduction52017236190.060 Why?
Gallium Radioisotopes120241950.060 Why?
Disease-Free Survival3201768500.050 Why?
Radiopharmaceuticals2202427040.050 Why?
Mesenteric Veins12023870.050 Why?
RNA, Small Interfering1201234250.050 Why?
Contrast Media1201653290.050 Why?
Fluorodeoxyglucose F182202220280.050 Why?
Cell Communication2200116600.050 Why?
Cell Adhesion2201730930.050 Why?
Carcinoembryonic Antigen120233370.050 Why?
Chlorambucil12002420.050 Why?
Survival Rate32022128250.050 Why?
Procarbazine120021720.050 Why?
Immunohistochemistry12016110610.050 Why?
Mice52024818890.050 Why?
CA-19-9 Antigen120221090.050 Why?
Combined Modality Therapy3202285400.050 Why?
Chemotherapy, Adjuvant2202035520.050 Why?
Vascular Endothelial Growth Factor A1201235110.050 Why?
Phosphorylation1201283070.050 Why?
Azacitidine120223350.050 Why?
Prednisolone120023260.050 Why?
Bleomycin120024920.050 Why?
Survival Analysis22012101000.050 Why?
Integrin alpha4beta1120011190.040 Why?
Nitrates120222600.040 Why?
GTP Phosphohydrolases120245250.040 Why?
Portal Vein120234370.040 Why?
Animals820241689300.040 Why?
Vinblastine120024820.040 Why?
Genes, MHC Class I120212360.040 Why?
Hematologic Tests120212390.040 Why?
Clinical Trials, Phase I as Topic120213290.040 Why?
Preoperative Period120225640.040 Why?
Microsatellite Repeats120217840.040 Why?
Blood Loss, Surgical120236420.040 Why?
Image Processing, Computer-Assisted1201689260.040 Why?
Edema120237640.040 Why?
Calcium Channel Blockers120226870.040 Why?
Clinical Trials, Phase II as Topic120216380.040 Why?
Cancer Care Facilities120214280.040 Why?
Plasma Membrane Calcium-Transporting ATPases12017170.040 Why?
Fibrosis1202420770.030 Why?
Pentose Phosphate Pathway120171260.030 Why?
Coculture Techniques1200113370.030 Why?
Monocarboxylic Acid Transporters12017810.030 Why?
Tomography, X-Ray Computed22021207080.030 Why?
Carcinoma, Renal Cell1201231860.030 Why?
Factor Analysis, Statistical1201910010.030 Why?
Digoxin120172460.030 Why?
Age Factors22023183970.030 Why?
Genetic Heterogeneity120197350.030 Why?
Antigens, Neoplasm1202419980.030 Why?
Autopsy1201910110.030 Why?
Granulocyte-Macrophage Colony-Stimulating Factor120198910.030 Why?
Propensity Score1202319720.030 Why?
Biological Specimen Banks120217870.030 Why?
Genotype12010130360.030 Why?
Culture120196220.030 Why?
Breast Neoplasms22020211620.030 Why?
Kidney Neoplasms1201242820.030 Why?
Job Satisfaction120195480.030 Why?
Doxorubicin1200222290.030 Why?
Radiotherapy, Adjuvant1202017870.030 Why?
Immunity1202110020.030 Why?
Neoplasm Recurrence, Local2202494040.030 Why?
Radiotherapy1202114970.030 Why?
Subcutaneous Fat120184010.030 Why?
Proto-Oncogene Proteins c-met120185620.030 Why?
Follow-Up Studies22013393090.030 Why?
Radiotherapy Dosage1202129110.030 Why?
Carbon120176730.030 Why?
Muscles1201815760.030 Why?
Cyclophosphamide1201922340.030 Why?
Organ Size1201822610.030 Why?
Research1202119770.030 Why?
Neoplasm Invasiveness1200136090.030 Why?
Glycosylphosphatidylinositols12012880.030 Why?
Immunologic Factors1202115940.030 Why?
Patient Participation1202114450.020 Why?
Calcium Signaling120177360.020 Why?
Gene Expression Regulation, Enzymologic1201711680.020 Why?
Peptides1202443440.020 Why?
Prospective Studies32021548710.020 Why?
Cell Cycle Proteins2201434390.020 Why?
Phosphatidylinositol 3-Kinase120121250.020 Why?
Radiotherapy, Intensity-Modulated120177940.020 Why?
Cell Division1199844740.020 Why?
Tumor Burden1201719000.020 Why?
Neoplasms, Experimental1201612270.020 Why?
Amino Acids1201717110.020 Why?
Medical Oncology1202223400.020 Why?
Polymorphism, Single Nucleotide12010160440.020 Why?
Proteasome Endopeptidase Complex1201713190.020 Why?
Macaca fascicularis120129080.020 Why?
Niacinamide120124190.020 Why?
DNA Mutational Analysis1201841140.020 Why?
Lymphopenia120122990.020 Why?
Hydroxamic Acids120124830.020 Why?
Transfection1201757540.020 Why?
Cell Survival1199857480.020 Why?
Biopsy1202067790.020 Why?
DNA Methylation1202244270.020 Why?
Guidelines as Topic1201413940.020 Why?
Lymphoma, Non-Hodgkin1199513740.020 Why?
United States32021729510.020 Why?
Area Under Curve1201216380.020 Why?
Lung Neoplasms12012134850.020 Why?
Time Factors22021401490.020 Why?
Histone Deacetylase Inhibitors120127760.020 Why?
Kaplan-Meier Estimate1201765120.020 Why?
Sensitivity and Specificity12022146520.020 Why?
Neutropenia120128940.020 Why?
Disease Management1201725330.020 Why?
Gene Expression Profiling1202295250.020 Why?
Early Detection of Cancer1202032360.020 Why?
Immunotherapy1202147470.020 Why?
Health Personnel1201933840.020 Why?
Thalidomide120108860.020 Why?
Sex Factors12019106190.020 Why?
Pyrimidines1201730430.010 Why?
Cell Movement1201751990.010 Why?
Fatigue1201215550.010 Why?
Protein Binding1201793200.010 Why?
Clinical Trials as Topic1202080450.010 Why?
Predictive Value of Tests12021154160.010 Why?
Risk Factors22020748810.010 Why?
Multivariate Analysis12017120640.010 Why?
Longitudinal Studies12020147620.010 Why?
Enzyme Inhibitors1201437210.010 Why?
Incidence12021215250.010 Why?
Proportional Hazards Models12017125340.010 Why?
Logistic Models12017132780.010 Why?
Apoptosis1199895130.010 Why?
Computer Simulation1201662590.010 Why?
Databases, Factual1201780660.010 Why?
Cell Proliferation12017104450.010 Why?
Gene Expression Regulation, Neoplastic1201786210.010 Why?
Genetic Predisposition to Disease12020180750.010 Why?
Weekes's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (301)
Explore
_
Co-Authors (120)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.